| Institution: | 1. Pharmacy and Clinical Pharmacy Department, Bordeaux University Hospital, F-33000 Bordeaux, France;2. Pediatric Department, Pellegrin Hospital, Bordeaux University Hospital, F-33000 Bordeaux, France;3. Infectious and Tropical Diseases Department, Pellegrin Hospital, Bordeaux University Hospital, F-33000 Bordeaux, France;4. USC EA 3671, Mycoplasma and Chlamydia Human Infections, Bordeaux University Hospital, F-33000 Bordeaux, France;1. Erasmus University Medical Center, Rotterdam, The Netherlands;2. Medicines Evaluation Board, The Netherlands;3. University of Bath, Bath, United Kingdom;4. Brighton Collaboration Foundation, Basel, Switzerland;5. Statens Serum Institut, Copenhagen, Denmark;6. Swedish Institute for Infectious Disease Control, Lund, Sweden;7. The Karolinska Institute, Stockholm, Sweden;8. Danish Center for Sleep Medicine, Copenhagen, Denmark;9. National Institute of Public Health, Bilthoven, The Netherlands;10. Helsingin Uniklinikka, Helsinki, Finland;11. Italian Medicines Agency, Rome, Italy;12. Regional Health Authority, Tuscany, Italy;13. Department of Neurological Sciences, University of Bologna, Bologna, Italy;14. Regional Health Authority, Emilia Romagna, Italy;15. Leiden University Medical Center, Leiden, The Netherlands;p. Department of Neurology, Donders Institute for Neuroscience, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands;q. European Centre for Disease Prevention and Control, Stockholm, Sweden;r. University Children''s Hospital, Basel, Switzerland |
